Expression of surface antigens on EryP/GFP+ cells during embryogenesis
Category and antigens . | 9.5 dpc . | 12.5 dpc . | 14.5 dpc . |
---|---|---|---|
Erythroid | |||
Ter119 | +++ | +++ | +++ |
CD71 | +++ | +++ | ++ |
Hematopoietic | |||
CD3 | − | − | − |
CD11b (Mac1) | − | − | − |
CD19 | − | − | − |
CD24 | +++ | +++ | +++ |
CD31 (PECAM1) | − | − | − |
CD34 | − | − | − |
CD41 | − | − | − |
CD45 | − | − | − |
CD48 | − | − | − |
CD55 (DAF) | +++ | +++ | +++ |
CD105 (Endoglin) | − | − | − |
CD117 (c-Kit) | − | − | − |
CD147 (Basigin) | +++ | +++ | +++ |
CD150 | − | − | − |
Flk1 | − | − | − |
Gr1 | − | − | − |
Sca-1 | − | − | − |
Adhesion molecules | |||
CD49d (α4 integrin) | − | + | ++ |
LPAM1 (α4β7 integrin) | − | − | − |
CD49e (α5 integrin) | ND | + | ++ |
CD49f (α6 integrin) | − | + | + |
CD44 | − | + | ++ |
MECA32 | − | − | − |
Growth factor receptors | |||
CD140a (PDGFRα) | − | − | − |
CD140b (PDGFRβ) | − | − | − |
CXCR4 | − | − | − |
Flt4 | − | − | − |
Category and antigens . | 9.5 dpc . | 12.5 dpc . | 14.5 dpc . |
---|---|---|---|
Erythroid | |||
Ter119 | +++ | +++ | +++ |
CD71 | +++ | +++ | ++ |
Hematopoietic | |||
CD3 | − | − | − |
CD11b (Mac1) | − | − | − |
CD19 | − | − | − |
CD24 | +++ | +++ | +++ |
CD31 (PECAM1) | − | − | − |
CD34 | − | − | − |
CD41 | − | − | − |
CD45 | − | − | − |
CD48 | − | − | − |
CD55 (DAF) | +++ | +++ | +++ |
CD105 (Endoglin) | − | − | − |
CD117 (c-Kit) | − | − | − |
CD147 (Basigin) | +++ | +++ | +++ |
CD150 | − | − | − |
Flk1 | − | − | − |
Gr1 | − | − | − |
Sca-1 | − | − | − |
Adhesion molecules | |||
CD49d (α4 integrin) | − | + | ++ |
LPAM1 (α4β7 integrin) | − | − | − |
CD49e (α5 integrin) | ND | + | ++ |
CD49f (α6 integrin) | − | + | + |
CD44 | − | + | ++ |
MECA32 | − | − | − |
Growth factor receptors | |||
CD140a (PDGFRα) | − | − | − |
CD140b (PDGFRβ) | − | − | − |
CXCR4 | − | − | − |
Flt4 | − | − | − |
Circulating GFP+ cells were assessed for surfce antigen expression by flow cytometry. Results represent data from at least 3 independent experiments.
— indicates antigen not detected on GFP+ cells; +, < 20% of GFP+ cells expressed antigen; ++, 20%-80% of GFP+ cells expressed antigen; +++, > 80 of GFP+ expressed antigen; ND, not determined; dpc, days after coitus.